{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "anxiety",
      "crocins",
      "flumazenil",
      "rat"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33266149",
  "DateCompleted": {
    "Year": "2021",
    "Month": "04",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "04",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "11",
        "Day": "30"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "5647",
      "10.3390/molecules25235647"
    ],
    "Journal": {
      "ISSN": "1420-3049",
      "JournalIssue": {
        "Volume": "25",
        "Issue": "23",
        "PubDate": {
          "Year": "2020",
          "Month": "Nov",
          "Day": "30"
        }
      },
      "Title": "Molecules (Basel, Switzerland)",
      "ISOAbbreviation": "Molecules"
    },
    "ArticleTitle": "The GABA<sub>A</sub>-Benzodiazepine Receptor Antagonist Flumazenil Abolishes the Anxiolytic Effects of the Active Constituents of <i>Crocus sativus</i> L. Crocins in Rats.",
    "Abstract": {
      "AbstractText": [
        "Anxiety is a chronic severe psychiatric disorder. Crocins are among the various bioactive components of the plant <i>Crocus sativus</i> L. (Iridaceae) and their implication in anxiety is well-documented. However, which is the mechanism of action underlying the anti-anxiety effects of crocins remains unknown. In this context, it has been suggested that these beneficial effects might be ascribed to the agonistic properties of these bioactive ingredients of saffron on the GABA type A receptor. The current experimentation was undertaken to clarify this issue in the rat. For this research project, the light/dark and the open field tests were used. A single injection of crocins (50 mg/kg, i.p., 60 min before testing) induces an anti-anxiety-like effect revealed either in the light-dark or open field tests. Acute administration of the GABA<sub>A</sub>-benzodiazepine receptor antagonist flumazenil (10 mg/kg, i.p., 30 min before testing) abolished the above mentioned anxiolytic effects of crocins. The current findings suggest a functional interaction between crocins and the GABA<sub>A</sub> receptor allosteric modulator flumazenil on anxiety."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Panepistimiou 3, 415-00 Larissa, Greece."
          }
        ],
        "LastName": "Pitsikas",
        "ForeName": "Nikolaos",
        "Initials": "N"
      },
      {
        "Identifier": [
          "0000-0002-5853-4780"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Chemistry, Department of Food Science and Human Nutrition, School of Food and Nutritional Sciences, Agricultural University of Athens, 118-55 Athens, Greece."
          }
        ],
        "LastName": "Tarantilis",
        "ForeName": "Petros A",
        "Initials": "PA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Molecules",
    "NlmUniqueID": "100964009",
    "ISSNLinking": "1420-3049"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "GABA-A Receptor Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Plant Extracts"
    },
    {
      "RegistryNumber": "12794-10-4",
      "NameOfSubstance": "Benzodiazepines"
    },
    {
      "RegistryNumber": "36-88-4",
      "NameOfSubstance": "Carotenoids"
    },
    {
      "RegistryNumber": "40P7XK9392",
      "NameOfSubstance": "Flumazenil"
    },
    {
      "RegistryNumber": "877GWI46C2",
      "NameOfSubstance": "crocin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "chemically induced",
        "drug therapy",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Behavior, Animal"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Benzodiazepines"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Carotenoids"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Crocus"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Flumazenil"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "GABA-A Receptor Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "toxicity"
      ],
      "DescriptorName": "Plant Extracts"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rats, Wistar"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}